CHARLESTON, W.Va. (AP) — The U.S. Drug Enforcement Administration has approved a rule change requiring drugmakers to identify a legitimate need for opioids to justify their production in an attempt to rein in their diversion for illicit purposes.
The DEA announced recently that the final rule sent for publication in the Federal Register will consider the extent to which a legally prescribed drug is diverted for abuse when the agency sets its annual opioid production limits.
The rule requires DEA to share notices of proposed aggregate production quotas and final aggregate production quota orders with state attorneys general.
Attorney General Jeff Sessions says the new rule “will allow the DEA to be more responsive to the facts on the ground.”
- Posted July 16, 2018
- Tweet This | Share on Facebook
Rule changes so drugmakers must justify need for opioids
headlines Macomb
- Multi-purpose: Attorney brings decades of experience to new role
- Court of Appeals vacates 25-year sentence for third-time drunken driver as disproportionate
- Eastpointe woman charged with animal torture moves toward trial
- Four juveniles charged with inciting a riot, malicious destruction of property
- State Bar seminar to focus on election law issues
headlines National
- Online shoppers find deals on the Temu app, but states say the trade-off is personal data
- Florida Bar reverses itself, says it is not investigating Lindsey Halligan
- Attorney indicted for trying to kill her husband of more than 25 years
- American Bar Association cites members’ needs in law firm intimidation hearing
- OpenAI sued for practicing law without a license
- Lindsey Halligan being investigated by the Florida Bar
